Salipada, Badria A.
HRN: 23-95-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
MUPIROCIN 2%, 15G (TUBE)
10/25/2023
10/31/2023
TOPICAL
2%
BID
Infected Wound, 1st Digit, Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes